4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-23-018361
Chief Financial Officer sold 37,062 shares at $4.75 ($176,119)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-23 | Sale : show line 1 in the form 10b5-1 | −37,062 | $4.75 | $176,119 | 46,120 | D |
| Open-market sales · 37,062 sh · avg $4.75 · $176,119 | ||||||
Loading xslF345X05/doc4.xml…